Skip to content
10-Q

Quarterly Report

Amphastar Pharmaceuticals, Inc. AMPH

0001297184-25-000050

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 46.5M sh
Shares Diluted Q2 2025 · Jun 30, 2025 48.13M sh
Shares Diluted Q2 2025 · Jun 30, 2025 49.01M sh
Shares Diluted Q2 2025 · Jun 30, 2024 52.05M sh
Shares Diluted Q2 2025 · Jun 30, 2024 52.53M sh
Stock Repurchased Q2 2025 · Jun 30, 2025 $50.22M
Stock Repurchased Q2 2025 · Jun 30, 2024 $8.5M
Capex Q2 2025 · Jun 30, 2025 $21.26M
Capex Q2 2025 · Jun 30, 2024 $14.84M
Operating Cash Flow Q2 2025 · Jun 30, 2025 $70.67M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $124.4M
Short Term Investments Q2 2025 · Jun 30, 2025 $44.06M
Short Term Investments Q2 2025 · Dec 31, 2024 $70.04M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $187.69M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $151.61M
Current Liabilities Q2 2025 · Jun 30, 2025 $176.41M
Current Liabilities Q2 2025 · Dec 31, 2024 $173.76M
Total Liabilities Q2 2025 · Jun 30, 2025 $857.85M
Total Liabilities Q2 2025 · Dec 31, 2024 $845.17M
Current Assets Q2 2025 · Jun 30, 2025 $580.83M
Current Assets Q2 2025 · Dec 31, 2024 $534.07M
Total Assets Q2 2025 · Jun 30, 2025 $1.62B
Total Assets Q2 2025 · Dec 31, 2024 $1.58B
Eps Diluted Q2 2025 · Jun 30, 2025 $0.64
Eps Diluted Q2 2025 · Jun 30, 2025 $1.15
Eps Diluted Q2 2025 · Jun 30, 2024 $0.73
Eps Diluted Q2 2025 · Jun 30, 2024 $1.54
Eps Basic Q2 2025 · Jun 30, 2025 $0.66
Eps Basic Q2 2025 · Jun 30, 2025 $1.19
Eps Basic Q2 2025 · Jun 30, 2024 $0.77
Eps Basic Q2 2025 · Jun 30, 2024 $1.67
Sga Expense Q2 2025 · Jun 30, 2025 $13.99M
Sga Expense Q2 2025 · Jun 30, 2025 $29.99M
Sga Expense Q2 2025 · Jun 30, 2024 $13.29M
Sga Expense Q2 2025 · Jun 30, 2024 $28.96M
Rd Expense Q2 2025 · Jun 30, 2025 $20.08M
Rd Expense Q2 2025 · Jun 30, 2025 $40.18M
Rd Expense Q2 2025 · Jun 30, 2024 $17.65M
Rd Expense Q2 2025 · Jun 30, 2024 $34.7M
Net Income Q2 2025 · Jun 30, 2025 $31.03M
Net Income Q2 2025 · Jun 30, 2025 $56.32M
Net Income Q2 2025 · Mar 31, 2025 $25.29M
Net Income Q2 2025 · Jun 30, 2024 $37.95M
Net Income Q2 2025 · Jun 30, 2024 $81.13M
Net Income Q2 2025 · Mar 31, 2024 $43.18M
Operating Income Q2 2025 · Jun 30, 2025 $42.18M
Operating Income Q2 2025 · Jun 30, 2025 $79.48M
Operating Income Q2 2025 · Jun 30, 2024 $55.22M
Operating Income Q2 2025 · Jun 30, 2024 $103.23M
Gross Profit Q2 2025 · Jun 30, 2025 $86.49M
Gross Profit Q2 2025 · Jun 30, 2025 $171.74M
Gross Profit Q2 2025 · Jun 30, 2024 $95.17M
Gross Profit Q2 2025 · Jun 30, 2024 $185.27M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $87.92M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $173.2M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $87.23M
Cost Of Revenue Q2 2025 · Jun 30, 2024 $168.96M
Revenue Q2 2025 · Jun 30, 2025 $174.41M
Revenue Q2 2025 · Jun 30, 2025 $344.94M
Revenue Q2 2025 · Jun 30, 2024 $182.39M
Revenue Q2 2025 · Jun 30, 2024 $354.23M